Wits Health Consortium (Pty) Ltd   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Johannesburg South Africa (1998)

Organization Overview

First Clinical Trial
2019
NCT03986970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinical HIV Research Unit t/a Wits Health Consortium | Clinical HIV Reserach Unit, Wits Health Consortium | Fatima Mayat | Wits Health Consortium (Pty) Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Coronavirus Infections (Phase 2)

Extensively Drug-Resistant Tuberculosis (Phase 3)

HIV Infections (Phase 2)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 21